Front. Cardiovasc. Med. Frontiers in Cardiovascular Medicine Front. Cardiovasc. Med. 2297-055X Frontiers Media S.A. 10.3389/fcvm.2024.1392484 Cardiovascular Medicine Correction Corrigendum: Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results PlášekJiří 1 2 * DodulíkJozef 1 LazárováMarie 1 StejskalDavid 3 4 ŠvageraZdeněk 3 4 ChobolováNela 3 ŠulcPatrik 1 EvinLukáš 1 2 PurováDana 5 VáclavíkJan 1 2 Department of Internal Medicine and Cardiology, University Hospital Ostrava, Ostrava, Czechia Research Center for Internal and Cardiovascular Diseases Faculty of Medicine, University of Ostrava, Ostrava, Czechia Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czechia Institute of Laboratory Medicine, University of Ostrava, Ostrava, Czechia Social Health Institute, Palacky University Olomouc, Olomouc, Czechia

Edited and Reviewed by: Matteo Cameli, University of Siena, Italy

 Correspondence: Jiří Plášek jiri.plasek@fno.cz 03042024 2024 111392484 27022024 19032024 © 2024 Plášek, Dodulík, Lazárová, Stejskal, Švagera, Chobolová, Šulc, Evin, Purová and Václavík. 2024Plášek, Dodulík, Lazárová, Stejskal, Švagera, Chobolová, Šulc, Evin, Purová and Václavík

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 secretoneurin heart failure CaMKII dilated cardiomyopathy ischaemic cardiomyopathy section-at-acceptanceHeart Failure and Transplantation A Corrigendum on Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results By Plášek J, Dodulík J, Lazárová M, Stejskal D, Švagera Z, Chobolová N, Šulc P, Evin L, Purová D and Václavík J. (2023). Front. Cardiovasc. Med. doi: 10.3389/fcvm.2023.1297900

In the published article, there were multiple errors in Table 2 as published. The values in Table 2 as seen below have been corrected.

Baseline characteristics of the healthy volunteers.

Healthy volunteers Males Females P value
N = 34 N = 13 N = 21
Age (years) 31 ± 7.1 30.8 ± 7.1 29.9 ± 6.9 0.596
Secretoneurin 50.7 ± 16.3 50.7 ± 15.3 50.7 ± 16.3 0.64
Body weight (kg) 69 ± 14 69 ± 14 67 ± 14 0.001
Body height (cm) 171.8 ± 8.9 171.8 ± 8.9 170.8 ± 8.9 <0.001
Body mass index (kg/m2) 23.2 ± 3.6 23.1 ± 3.6 23 ± 3.6 0.477
NT-pro-BNP 55.5 ± 29.2 55.5 ± 29.2 57.5 ± 30 0.066
Creatinine 74.1 ± 12.45 74.1.1 ± 12.45 71.9 ± 10.6 <0.001
Natrium 138.2 ± 1.75 138.2 ± 1.75 138.2 ± 1.76 0.208
Potassium 4.1 ± 0.29 4.1 ± 0.29 4.1 ± 0.3 0.03
Ca2+ (ionized) 1.17 ± 0.1 1.2 ± 0.1 1.17 ± 0.1 0.519
Total calcium 2.48 ± 0.13 2.48 ± 0.11 2.48 ± 0.13 0.079
Mg2+ 0.79 ± 0.1 0.79 ± 0.1 0.79 ± 0.05 0.341
hs-TnI 8.1 ± 29.4 8.1 ± 29.42 8.6 ± 31 0.195
Hs-CRP 1.8 ± 2.36 1.8 ± 2.4 2 ± 2.4 0.026
IL-6 3.1 ± 2.6 3.1 ± 2.6 3.2 ± 2.8 0.440
Leukocytes 7.52 ± 1.7 7.5 ± 1.7 7.5 ± 1.6 0.201
Thrombocytes 280 ± 59.1 280 ± 59.1 281.8 ± 59 0.013

Indices are shown as mean ± standard deviation and compared for males and females. Ca2+, ionized calcium; Hs-TnI, high-sensitivity Troponine I; IL-6, interleukin 6; Mg2+, ionized magnesium; NT-pro-BNP, N-terminal-pro-brain natriuretic peptide.

The corrected Table 2 and its caption appear below.

Baseline characteristics of the healthy volunteers.

Healthy volunteers Males Females P value
N = 34 N = 13 N = 21
Age (years) 31 ± 7.1 30.8 ± 7.1 29.9 ± 6.9 0.596
Secretoneurin 50.3 ± 15 50.2 ± 15.1 50.7 ± 15.5 0.64
Body weight (kg) 69.1 ± 13.5 70 ± 14 66.6 ± 13 0.47
Body height (cm) 171.1 ± 8.9 172 ± 8.7 170.6 ± 8.8 0.52
Body mass index (kg/m2) 23.2 ± 3.6 23.1 ± 3.6 23 ± 3.6 0.477
NT-pro-BNP 55.4 ± 28.7 58.1 ± 31.4 53.6 ± 28.9 0.066
Creatinine 73 ± 10.9 75.6 ± 10.1 72.3 ± 10.3 0.36
Natrium 138.2 ± 1.73 138 ± 1.8 138.1 ± 1.7 0.208
Potassium 4.1 ± 0.3 4.1 ± 0.29 4.1 ± 0.3 0.03
Ca2+ (ionized) 1.17 ± 0.1 1.2 ± 0.1 1.17 ± 0.1 0.519
Total calcium 2.48 ± 0.13 2.48 ± 0.11 2.48 ± 0.13 0.079
Mg2+ 0.79 ± 0.1 0.79 ± 0.1 0.79 ± 0.05 0.341
hs-TnI 8.6 ± 30 10.2 ± 34.2 8.8 ± 30.1 0.9
Hs-CRP 1.9 ± 2.4 1.5 ± 1.7 2 ± 2.4 0.45
IL-6 3.1 ± 2.6 3.1 ± 2.6 3.2 ± 2.8 0.440
Leukocytes 7.52 ± 1.7 7.5 ± 1.7 7.5 ± 1.6 0.201
Thrombocytes 277.5 ± 59.8 271.3 ± 64 280.4 ± 59.8 0.69

Indices are shown as mean ± standard deviation and compared for males and females. Ca2+, ionized calcium; Hs-TnI, high-sensitivity Troponine I; IL-6, interleukin 6; Mg2+, ionized magnesium; NT-pro-BNP, N-terminal-pro-brain natriuretic peptide.

The authors apologize for this errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

In the published article, there was an error in assumptions about differences in males and females in the healthy volunteers group.

A correction has been made to Results. This sentence previously stated:

“Males and females in the healthy individuals group differed in anthropometric parameters, plasma creatinine level, hs-CRP, and thrombocyte count (Table 2)”.

The corrected sentence appears below:

“Males and females in the healthy individuals’ group did not differ in any parameters (Table 2)”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.